Related Experiment Video

Updated: Jul 16, 2026

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model
08:23

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

Manipulation of the nerve growth factor network in prostate cancer

Athanasios G Papatsoris1, Danae Liolitsa, Charalambos Deliveliotis

  • 12nd Department of Urology, University of Athens, School of Medicine, Sismanoglio General Hospital, Athens, Greece. agpapatsoris@yahoo.gr

Expert Opinion on Investigational Drugs
|February 17, 2007
PubMed

Insights

Nerve growth factor (NGF) signaling, particularly the balance between TrkA and p75 neurotrophin receptor (p75(NTR)), is crucial in prostate cancer. Targeting NGF pathways offers a promising therapeutic strategy for prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Nerve growth factor (NGF) and its receptors (p75 neurotrophin receptor [p75(NTR)] and tropomyosin receptor kinase A [TrkA]) are implicated in prostate carcinogenesis.
  • p75(NTR) acts as a tumor and metastasis suppressor, and its loss correlates with prostate cancer progression.

Purpose of the Study:

  • To review the role of NGF signaling in prostate carcinogenesis.
  • To explore the therapeutic potential of targeting NGF pathways in prostate cancer.

Main Methods:

  • Literature review of studies on NGF, its receptors, and prostate cancer.
  • Analysis of signaling pathways involving TrkA and p75(NTR) in cancer progression.
  • Examination of the effects of NGF and GnRH analogs on prostate cancer cells.

Main Results:

  • An imbalance between TrkA and p75(NTR) signaling may drive prostate cancer progression via increased proliferation and reduced apoptosis.
  • NGF administration can revert malignant phenotypes in prostate cancer cells.
  • Trk inhibition presents a novel therapeutic approach for prostate cancer.

Conclusions:

  • The NGF signaling network is a critical target for pharmacological manipulation in prostate cancer.
  • Understanding the NGF 'circuitry' can lead to the development of new therapeutic agents for prostate cancer.

More Related Videos

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...